Edwards Lifesciences (EW) Proxy Filing summary

Executive summary

• Annual meeting scheduled for May 8, 2025, at 10:00 a.m. Pacific Time, online; stockholders of record as of March 11, 2025, are eligible to vote.

• The board recommends voting FOR all proposals on the meeting agenda.

Voting matters and shareholder proposals

• Five agenda items: director elections, advisory vote on named executive officer compensation, auditor ratification, and amendments to the U.S. and international ESPPs.

Board of directors and corporate governance

• Nine director nominees: Leslie C. Davis, David T. Feinberg, Kieran T. Gallahue, Leslie S. Heisz, Paul A. LaViolette, Steven R. Loranger, Ramona Sequeira, Nicholas J. Valeriani and Bernard J. Zovighian.